NYSE: PMPhilip Morris International Inc Stock
$177.72-3.48 (-1.92%)
Updated Jul 8, 2025
PM Price
$177.72
Fair Value Price
N/A
Market Cap
$276.62B
52 Week Low
$101.68
52 Week High
$186.69
P/E
36.49x
P/B
-25.38x
P/S
6.43x
PEG
1.53x
Dividend Yield
3.04%
Revenue
$38.39B
Earnings
$7.60B
Gross Margin
65.7%
Operating Margin
30.44%
Profit Margin
19.8%
Debt to Equity
-6.79
Operating Cash Flow
$12B
Beta
0.38
Next Earnings
Jul 21, 2025
Ex-Dividend
Jun 27, 2025
Next Dividend
Jul 15, 2025
PM Overview
Philip Morris International Inc. a tobacco company that is evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its current product portfolio includes cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products sold in markets outside the U.S. Its cigarette brands include Marlboro, Bond Street, Chesterfield, L&M, Lark, and Philip Morris. PMI was incorporated in 1987 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Tobacco
Industry Rating
C
PM
Ranked#2 of 8
Ranked#2 of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $71.37 | C | |
| $47.93 | C | |
| $59.54 | C |
Be the first to know about important PM news, forecast changes, insider trades & much more!
PM News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PM ($177.72) is trading above its intrinsic value of $67.76, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PM is poor value based on its earnings relative to its share price (36.49x), compared to the US market average (30.75x)
P/E vs Market Valuation
PM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PM due diligence checks available for Premium users.
Valuation
PM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
36.49x
Industry
29x
Market
30.75x
PM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-25.38x
Industry
9.85x
PM price to earnings growth (PEG)
For valuing profitable companies with growth potential
PM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PM's financial health
Profit margin
Revenue
$9.3B
Net Income
$2.7B
Profit Margin
28.9%
PM's Earnings (EBIT) of $11.68B... subscribe to Premium to read more.
Interest Coverage Financials
PM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$65.1B
Liabilities
$74.0B
Debt to equity
-6.79
PM's short-term liabilities ($28.09B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PM's long-term liabilities ($45.92B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$350.0M
Investing
-$434.0M
Financing
$671.0M
PM's operating cash flow ($11.63B)... subscribe to Premium to read more.
Debt Coverage Financials
PM vs Tobacco Stocks
Philip Morris International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.